Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    5.00 (0.97%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Acquisition

30 Mar 2012 07:00

Anpario plc ("Anpario", the "Company" or the "Group")

Acquisition of Meriden Animal Health Limited

Highlights

Acquisition of Meriden Animal Health Limited ("Meriden") for up to £4.125 million Meriden's 2011 sales and adjusted profit before interest and tax were £5.35 million and £740,000 respectively Expected to be immediately earnings enhancing Deal increases Anpario's global market share and significantly strengthens its position in China Consideration to be met from the Company's existing cash resources

Anpario plc, one of the leading suppliers of natural high performance feed additives to enhance health, growth and sustainability in global agriculture and aquaculture markets, is pleased to announce the acquisition of Meriden Animal Health Limited for a total consideration of up to £4.125 million.

The acquisition of Meriden brings another strong trading brand to the Anpario Group, broadening its product technology and increasing Anpario's global market share in the feed additive sector.

Meriden based in Bedfordshire in the United Kingdom, supplies the global agriculture and aquaculture markets with natural animal feed additive products. Meriden's Orego-Stim range of products, using essential oils, is the leading brand in its field and is marketed across 60 countries worldwide, with the majority of sales being outside the United Kingdom

Meriden's sales for the 12 months to December 2011 were £5.35 million and adjusted profit before interest and tax was £740,000. Net assets acquired will be at least £1.644 million, the majority being working capital, including cash in excess of £400,000. The acquisition is expected to be immediately earnings enhancing to the Group as a whole.

Meriden has ten full time staff including a technical support team based in a representative office in Malaysia. The majority of production is outsourced to a third party manufacturer based in the United Kingdom. Meriden typically supplies through distributors in the local territories except Australia where the company has a joint venture company.

Meriden has a close and important partnership with its China operation with sales accounting for 26% of Meriden's total sales during 2011. The China business has been growing well and Anpario intends to give further support to this relationship to capitalise on the vast potential of China's agriculture market.

In line with Anpario's strategy, Meriden will be run as a separate business enabling the team to focus on selling and marketing high quality feed additive products around the world. Joining Anpario means Meriden's management team will gain additional support and can benefit from working together with Anpario's research and development resource to develop new and innovative products for sale under the Meriden brand.

The two shareholders and founders, namely, Stephen Harris, Managing Director, and Pamela McLaren, Company Secretary, are to remain with the business in their existing roles and will continue to develop the Meriden business further.

The price payable for Meriden is on a debt free basis but will include estimated excess cash of £400,000. An initial payment of £3.0 million in cash on completion has been made from existing cash resources. The remaining £1.125 million is payable over the next two years, dependent on Meriden achieving certain performance criteria, and of this, £125,000 is to be satisfied by the issue of ordinary shares of Anpario to Meriden's shareholders. Subsequent to the completion of this acquisition, Anpario's cash balances will be in excess of £2.5 million.

The Company expects to announce its results for the year ended 31 December 2011 on 26 April 2012.

Richard Edwards, Executive Vice Chairman of Anpario, commented:

"Meriden Animal Health is a quality business with strong brand recognition for developing 100% natural feed additives. This acquisition increases our global market share in animal feed additives which is benefiting as the agriculture industry looks to use natural based solutions to promote the health and growth of animals for meat consumption.

Meriden's significant presence in China increases our involvement in the world's biggest producer of poultry and pig meat and reinforces our strategy to build more significant positions in emerging agriculture and aquaculture markets. We are delighted to welcome the Meriden team and very much look forward to working with them in achieving continued success with the business."

Enquiries:

Anpario plcRichard Edwards, Executive Vice Chairman +44 (0)7776 417129Karen Prior, Group Finance Director +44 (0)1909 537380

FinnCap +44 (0)20 7600 1658Matthew Robinson / Henrik Persson - Corporate FinanceStephen Norcross - Corporate Broking

Copyright Business Wire 2012

Date   Source Headline
27th Jan 20117:00 amBUSTransaction in Own Shares
20th Jan 20119:51 amBUSHolding(s) in Company
11th Oct 20107:00 amBUSKiotech International plc ("Kiotech") Acquisition of long leasehold interest
1st Oct 20102:29 pmRNSResult of EGM
20th Sep 20107:00 amBUSDirector/PDMR Shareholding
15th Sep 20107:00 amBUSHalf-yearly Report
7th Sep 20107:00 amBUSPosting of notice of General Meeting
6th Sep 20107:00 amBUSAcquisition of long leasehold interest
11th Aug 20107:00 amBUSTrading Statement
29th Jul 20105:47 pmBUSHolding(s) in Company
30th Jun 201011:58 amRNSResult of AGM
15th Jun 20105:17 pmRNSHolding(s) in Company
8th Jan 20102:34 pmRNSChange of Registered Office
13th Nov 20092:16 pmRNSDirectorate Change
13th Nov 20092:10 pmRNSPayment of dividend and proceeds of redemption
5th Nov 20092:01 pmRNSDe-listing from LSE
29th Oct 20092:00 pmRNSDividend Declaration
28th Oct 20092:19 pmRNSDirectorate Change
13th Aug 200912:00 pmRNSDirector/PDMR Shareholding
6th Aug 200911:39 amRNSDirector/PDMR Shareholding
27th Jul 20097:00 amRNSAnglo Platinum Interim Results
27th Jul 20097:00 amRNSAnglo Platinum Interim Results
24th Jul 20093:00 pmRNSDirectorate Change
17th Jul 200912:00 pmRNSChange to the Board of Directors
9th Jul 200910:58 amRNSBlocklisting Interim Review
9th Jul 200910:57 amRNSBlocklisting Interim Review
24th Jun 20094:00 pmRNSDirector/PDMR Shareholding
5th Jun 20092:58 pmRNSDealings by a director of major subsidiary
4th Jun 20093:08 pmRNSDirector/PDMR Shareholding
14th May 20093:01 pmRNSBEE transaction revised terms
30th Apr 20098:25 amRNSQuarterly Review and Production Report
29th Apr 200912:00 pmRNSDeclaration of preference dividend
30th Mar 20094:00 pmRNSResults of AGM
26th Mar 20099:24 amRNSNotice of AGM
13th Mar 200911:29 amRNSDirector/PDMR Shareholding
5th Mar 200911:10 amRNSDirectorate Change
12th Feb 20099:24 amRNSDirector/PDMR Shareholding
9th Feb 200910:38 amRNSFinal Results
9th Feb 20097:00 amRNSAnglo Platinum Results
9th Feb 20097:00 amRNSFinal Results
6th Jan 20092:14 pmRNSDirectorate Change
6th Jan 20097:00 amRNSBlocklisting Interim Review
6th Jan 20097:00 amRNSBlocklisting Interim Review
15th Dec 20083:30 pmRNSDirector/PDMR Shareholding
8th Dec 20083:30 pmRNSTiming of capex review
12th Nov 20089:30 amRNSAgreements with Anglo Platinum & Northam Platinum
5th Nov 20082:32 pmRNSSmelter Shutdown
4th Nov 20082:00 pmRNSDirector/PDMR Shareholding
27th Oct 20082:00 pmRNSDividend Declaration
23rd Oct 20082:57 pmRNSBEE restructuring agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.